Medicenna Therapeutics Net Tangible Assets

Medicenna Therapeutics (MDNA) currently reports a net tangible assets of $23M as of September 2023. That compares with $34M in the prior-year period — down 30.9% year over year. Use the charts on this page to explore Medicenna Therapeutics's net tangible assets history and peer comparisons.

Medicenna Therapeutics's net tangible assets decreased from $34M to $23M — a 30.9% year-over-year decrease (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Medicenna Therapeutics reported $23M in net tangible assets as of September 2023. That compares with $34M in the prior-year period — down 30.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $23M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Medicenna Therapeutics, and consider following MDNA for alerts when major investors trade the stock.

Medicenna Therapeutics is classified in the Healthcare sector. On net tangible assets, it currently shows $23M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing MDNA with unrelated industries.